HOXD13 and neoplasm: NDV-αCTLA-4 and NDV-sPD-1 (5 × 107 PFU) were then injected intratumorally and tissues, including the tumor, heart, liver, both kidneys, tumor-draining inguinal lymph node, axillary lymph node, and serum were collected at 12- and 36-h after administration of NDV.